225 related articles for article (PubMed ID: 17031871)
1. Bombesin analogs containing alpha-amino-isobutyric acid with potent anticancer activity.
Prasad S; Mathur A; Gupta N; Jaggi M; Singh AT; Rajendran P; Sanna VK; Datta K; Mukherjee R
J Pept Sci; 2007 Jan; 13(1):54-62. PubMed ID: 17031871
[TBL] [Abstract][Full Text] [Related]
2. Substance P analogs containing alpha,alpha-dialkylated amino acids with potent anticancer activity.
Prasad S; Mathur A; Jaggi M; Singh AT; Mukherjee R
J Pept Sci; 2007 Aug; 13(8):544-8. PubMed ID: 17617800
[TBL] [Abstract][Full Text] [Related]
3. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological activity of cell-penetrating peptide-modified octreotide analogs.
Xie W; Liu J; Qiu M; Yuan J; Xu A
J Pept Sci; 2010 Feb; 16(2):105-9. PubMed ID: 20014325
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
6. Novel nontoxic heat shock protein 90 inhibitors having selective antiproliferative effect.
Orosz A; Szabo A; Szeman G; Janaky T; Somlai C; Penke B; Bodor A; Perczel A
Int J Biochem Cell Biol; 2006; 38(8):1352-62. PubMed ID: 16540363
[TBL] [Abstract][Full Text] [Related]
7. Delivering multiple anticancer peptides as a single prodrug using lysyl-lysine as a facile linker.
Prasad S; Mathur A; Jaggi M; Mukherjee R
J Pept Sci; 2007 Jul; 13(7):458-67. PubMed ID: 17559067
[TBL] [Abstract][Full Text] [Related]
8. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
9. Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
Szepeshazi K; Schally AV; Treszl A; Seitz S; Halmos G
Anticancer Drugs; 2008 Apr; 19(4):349-58. PubMed ID: 18454045
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes.
Zhang J; Liu L; Gong Y; Zheng X; Yang M; Cui J; Shen S
Eur J Med Chem; 2009 May; 44(5):2322-7. PubMed ID: 18524422
[TBL] [Abstract][Full Text] [Related]
11. Potential new antitumor agents from an innovative combination of camphorato, a ramification of traditional Chinese medicine, with a platinum moiety.
Wang L; Gou S; Chen Y; Liu Y
Bioorg Med Chem Lett; 2005 Jul; 15(14):3417-22. PubMed ID: 15953727
[TBL] [Abstract][Full Text] [Related]
12. Antitumor agents 243. Syntheses and cytotoxicity of desmosdumotin C derivatives.
Nakagawa-Goto K; Wu JH; Bastow KF; Wu CC; Lee KH
Bioorg Med Chem; 2005 Mar; 13(6):2325-30. PubMed ID: 15727881
[TBL] [Abstract][Full Text] [Related]
13. Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: relevance to physicochemical properties.
Mizejewski GJ; Eisele L; Maccoll R
Anticancer Res; 2006; 26(4B):3071-6. PubMed ID: 16886636
[TBL] [Abstract][Full Text] [Related]
14. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro and in vivo evaluation of a series of dihydroisocoumarin derivatives conjugated with fatty acids, alcohols, and amines as potential anticancer agents.
Higgins CA; Delbederi Z; McGarel K; Mills T; McGrath O; Feutren-Burton S; Watters W; Armstrong P; Johnston PG; Waugh D; van den Berg H
Bioconjug Chem; 2009 Sep; 20(9):1737-51. PubMed ID: 19708666
[TBL] [Abstract][Full Text] [Related]
16. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 1-(3',4',5'-trimethoxy) phenyl naphtho[2,1b]furan as a novel anticancer agent.
Srivastava V; Negi AS; Kumar JK; Faridi U; Sisodia BS; Darokar MP; Luqman S; Khanuja SP
Bioorg Med Chem Lett; 2006 Feb; 16(4):911-4. PubMed ID: 16297622
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice.
Gil-Ad I; Zolokov A; Lomnitski L; Taler M; Bar M; Luria D; Ram E; Weizman A
Int J Oncol; 2008 Aug; 33(2):277-86. PubMed ID: 18636148
[TBL] [Abstract][Full Text] [Related]
19. Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice.
Sun L; Vasilevich NI; Fuselier JA; Coy DH
Anticancer Res; 2004; 24(1):179-86. PubMed ID: 15015595
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity, qualitative structure-activity relationship (QSAR), and anti-tumor activity of bismuth dithiocarbamate complexes.
Li H; Lai CS; Wu J; Ho PC; de Vos D; Tiekink ER
J Inorg Biochem; 2007 May; 101(5):809-16. PubMed ID: 17363061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
